Por: Associated Press Health January 09, 2023
TAIPEI, Taiwan (AP) — China’s health care authorities declined to include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. Paxlovid, an oral medicine developed by New York-based drugmaker Pfizer, has been widely sought after in China since the country began and a . Although it is supposed to be prescribed by... + full article
Newsweek USA Business February 06, 2023
Pfizer's involvement with the 2023 Grammy Awards sparked speculation online, with some viewers wondering how much input the pharmaceutical company had.The annual music ceremony was held at the Crypto.com Arena in Los Angeles, California on Sunday night, with Beyoncé... + más
Here's how to watch the 2023 Grammys on iPhone, iPad, Apple TV, and more | 9to5Mac
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. | MarketWatch
Newsweek USA Business February 02, 2023
Pharmaceutical giant Pfizer has been accused of making an obscene profit from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year.The company's COVID products Comirnaty, an mRNA vaccine and... + más
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
ESPN USA Sports November 28, 2022
CHARLOTTE, N.C. -- In a season in which the only thing the can consistently do, it seems, is raise their own frustration level with one loss after another, a brief sideline blowup between defensive tackle and quarterback was caught on camera Sunday.It came early in the fourth... + más
'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News
Sources: Denver Broncos RB Javonte Williams out for season with torn ACL, LCL | ABC News
Los Angeles Times USA Science November 14, 2022
This is a story about a COVID-19 medication, a nasty trick the coronavirus sometimes plays on its victims, and how the two became a pandemic couple called “Paxlovid rebound.” It's also a story about how looks can be deceiving. Americans have been quick to embrace the... + más
Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN
Paxlovid rebound more common than initially thought, doctors say | ABC News
ABC News USA Health November 10, 2022
Six months ago, Dr. Joseph Boselli said he was prescribing the antiviral drug Paxlovid to nearly everyone who turned up at his practice with COVID.Now, the internal medicine physician at Jefferson Health in Philadelphia said he's reserving it mostly for people who are... + más
For some COVID patients, 'Paxlovid rebound' has nothing to do with Paxlovid | Los Angeles Times
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
CNN USA Health October 14, 2022
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most... + más
Pfizer pledges $120M to produce oral COVID-19 treatment Paxlovid at Michigan factory | New York Daily News
Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11 | MarketWatch
About iurex | Privacy Policy | Disclaimer |